Refine by
Diagnostic Device Development Software
6 software items found
by:SaralPro Technologies Pvt. Ltd based inMeerut, INDIA
Diagnostic Careis an integrated, modular client server based system working around a common database. The Solution is developed across diagnostic care using the computing technologies including RDBMS, LAN and ...
Manufactured by:Sanrai International based inEndicott, NEW YORK (USA)
Developed in Australia, the ResApp is a digital solution to the challenges of diagnosing respiratory diseases. By using artificial intelligence, the ResApp listens to a patients cough sounds and enables rapid, low cost, point of care and remote diagnosis of respiratory diseases. Clinically validated to be over 85% accurate, the ResApp has the power to change how respiratory diseases are diagnosed ...
by:Flagship Biosciences Inc. based inBroomfield, COLORADO (USA)
Your next pathology-based CDx starts here. With the complexity of therapies increasing, the need for a robust companion diagnostic (CDx) has never been higher. Advances in tissue analysis technologies now require a more quantitative, accurate, and precise pathology-based CDx. Bringing your CDx to market requires a solid strategy to meet strict regulatory standards and critical timelines. Your CDx ...
by:Ovation based inPortland, MAINE (USA)
Ovation's genomic data solutions enable life science and biopharma companies to accelerate research and development across a wide range of therapeutic areas including autoimmune, metabolic, and infectious ...
by:Paige AI, Inc. based inNew York City, NEW YORK (USA)
Paige is pioneering novel predictive and prognostic tissue-based biomarkers from tissue. By combining leading technology with groundbreaking AI, Paige derives novel insights from images of routine hematoxylin and eosin (H&E) stained tissue to identify morphologic features and biomarkers with clinical utility. Using proprietary computational pathology with exclusive clinical data ...
Manufactured by:DNAiTECH Ltd based inBlenheim, NEW ZEALAND
DNAiTECH is advancing the field of in-field and point-of-care diagnostics with the development of innovative testing instruments. Their Gen3 platform, slated for release in 2024, aims to meet the World Health Organization's ASSURED criteria, encompassing affordability, sensitivity, user-friendliness, and robustness, among other factors. This platform incorporates microfluidics and LAMP-CRISPR ...